000 02137nam  2200385zi 4500
0019.906199
003CaOODSP
00520221107181042
006m     o  d f      
007cr mn|||||||||
008211220t20212021onc     o    f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH113-28/2021-9E-PDF
24500|aCymoxanil and its associated end-use products : |bfinal decision.
264 1|aOttawa, Ontario : |bPest Management Regulatory Agency, Health Canada, |c2021.
264 4|c©2021
300 |a1 online resource (10 pages).
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |aRe-evaluation decision, |x1925-1025 ; |vRVD2021-09
500 |a"16 December 2021."
500 |aCover title.
500 |aSummary issued also in HTML format.
500 |aIssued also in French under title: Cymoxanil et préparations commerciales connexes : décision finale.
520 |a"This document presents the final re-evaluation decision for the re-evaluation of cymoxanil, including the required amendments (risk mitigation measures) to protect human health and the environment, as well as label amendments required to bring labels to current standards. All products containing cymoxanil that are registered in Canada are subject to this re-evaluation decision"--Page 1.
650 0|aFungicides|xCertification|zCanada.
650 0|aFungicides|xToxicology.
650 0|aFungicides|xEnvironmental aspects.
7101 |aCanada. |bPest Management Regulatory Agency, |eissuing body.
77508|tCymoxanil et préparations commerciales connexes : |w(CaOODSP)9.906200
830#0|aRe-evaluation decision (Canada. Pest Management Regulatory Agency)|vRVD2021-09.|w(CaOODSP)9.505209
85640|qPDF|s544 KB|uhttps://publications.gc.ca/collections/collection_2021/sc-hc/h113-28/H113-28-2021-9-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/consumer-product-safety/reports-publications/pesticides-pest-management/decisions-updates/reevaluation-decision/2021/cymoxanil.html